 |
|||||||
|
|||||||
|
|
Your Resource on Authorized Generics Prasco is The Industry Resource on Authorized Generics. We have immersed ourselves in the study of the subject, its affects on the marketplace and on consumer behavior. Prasco’s position on authorized generics is congruent with that of the FDA, who stated:“Marketing of authorized generics increases competition, promoting lower prices for pharmaceuticals, particularly during the 180-day exclusivity period in which the prices for generic drugs are often substantially higher than after other generic products are able to enter the market.” Prasco applauds industry leaders who continue the investigation on this topic. While Prasco seeks opportunities to further educate audiences on the benefits of authorized generics, this Web page resource is intended to serve as an objective list of industry links and resources on the subject. Web Links Prasco Web site Studies and Reports FTC Report: Authorized Generics: Interim Report Related Links:
|
| Terms | Site Map | FAQ's | Privacy |
